Point72 Asset Management’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.9M	Buy	590,877 +165,725	+39%	+$4.23M	0.02%	1023
2025 Q4	$12.3M	Buy	+425,152	New	+$10.9M	0.02%	1228
2025 Q3	–	Sell	-1,485,425	Closed	-$20.8M	–	2324
2025 Q2	$20.8M	Buy	1,485,425 +654,947	+79%	+$9.18M	0.05%	479
2025 Q1	$13M	Sell	830,478 -923,044	-53%	-$13M	0.04%	587
2024 Q4	$24.4M	Buy	1,753,522 +1,509,136	+618%	+$16.5M	0.07%	394
2024 Q3	$2.27M	Buy	+244,386	New	+$2.41M	0.01%	1152
2024 Q1	–	Sell	-320,300	Closed	-$1.03M	–	2172
2023 Q4	$1.03M	Buy	+320,300	New	+$871K	﹤0.01%	1389
2023 Q1	–	Sell	-1,103,576	Closed	-$16.3M	–	2234
2022 Q4	$16.3M	Sell	1,103,576 -2,681,701	-71%	-$46.9M	0.06%	392
2022 Q3	$72.3M	Buy	3,785,277 +1,797,846	+90%	+$40.7M	0.31%	84
2022 Q2	$42.4M	Buy	1,987,431 +289,582	+17%	+$5.94M	0.2%	151
2022 Q1	$32.7M	Sell	1,697,849 -946,328	-36%	-$16M	0.14%	209
2021 Q4	$54.8M	Buy	2,644,177 +652,070	+33%	+$13M	0.24%	118
2021 Q3	$47.6M	Buy	1,992,107 +1,095,707	+122%	+$25M	0.23%	119
2021 Q2	$24.5M	Buy	896,400 +457,100	+104%	+$12.9M	0.12%	240
2021 Q1	$12.7M	Sell	439,300 -435,900	-50%	-$13.6M	0.06%	371
2020 Q4	$24.6M	Buy	875,200 +831,944	+1,923%	+$20.4M	0.13%	230
2020 Q3	$1.27M	Buy	+43,256	New	+$1.16M	0.01%	754